| MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer S Gawrzak, L Rinaldi, S Gregorio, EJ Arenas, F Salvador, J Urosevic, ... Nature cell biology 20 (2), 211-221, 2018 | 127 | 2018 |
| RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation M Morales, EJ Arenas, J Urosevic, M Guiu, E Fernández, E Planet, ... EMBO molecular medicine 6 (7), 865-881, 2014 | 84 | 2014 |
| FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth F Slebe, F Rojo, M Vinaixa, M García-Rocha, G Testoni, M Guiu, E Planet, ... Nature communications 7 (1), 11199, 2016 | 67 | 2016 |
| p95HER2–T cell bispecific antibody for breast cancer treatment I Rius Ruiz, R Vicario, B Morancho, CB Morales, EJ Arenas, S Herter, ... Science translational medicine 10 (461), eaat1445, 2018 | 64 | 2018 |
| Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification B Pellegrino, A Herencia-Ropero, A Llop-Guevara, F Pedretti, ... Cancer research 82 (8), 1646-1657, 2022 | 44 | 2022 |
| Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition F Mateo, EJ Arenas, H Aguilar, J Serra-Musach, GR De Garibay, J Boni, ... Oncogene 36 (19), 2737-2749, 2017 | 41 | 2017 |
| Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation EJ Arenas, A Martínez-Sabadell, I Rius Ruiz, M Román Alonso, ... Nature communications 12 (1), 1237, 2021 | 33 | 2021 |
| Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer A Adam-Artigues, EJ Arenas, A Martínez-Sabadell, F Brasó-Maristany, ... Science advances 8 (20), eabk2746, 2022 | 31 | 2022 |
| Ifnγ signaling in natural and therapy-induced antitumor responses A Martínez-Sabadell, EJ Arenas, J Arribas Clinical Cancer Research 28 (7), 1243-1249, 2022 | 18 | 2022 |
| The Transcription Factor SLUG Uncouples Pancreatic Cancer Progression from the RAF–MEK1/2–ERK1/2 Pathway F Bilal, EJ Arenas, K Pedersen, A Martínez-Sabadell, B Nabet, ... Cancer research 81 (14), 3849-3861, 2021 | 15 | 2021 |
| Therapy-induced senescence enhances the efficacy of HER2-targeted antibody–drug conjugates in breast cancer S Duro-Sánchez, M Nadal-Serrano, M Lalinde-Gutiérrez, EJ Arenas, ... Cancer research 82 (24), 4670-4679, 2022 | 11 | 2022 |
| Early-stage breast cancer detection in breast milk C Saura, C Ortiz, J Matito, EJ Arenas, A Suñol, Á Martín, O Córdoba, ... Cancer discovery 13 (10), 2180-2191, 2023 | 9 | 2023 |
| Relatos, sueños y arte de mi pueblo: Produciendo cronicas con estudiantes de la IE nuestra señora de la presentacion M Morales, E Arenas Tesis de maestría). Universidad Tecnológica de Pereira, Pereira. Recuperada …, 2017 | 9 | 2017 |
| The target antigen determines the mechanism of acquired resistance to T cell-based therapies A Martínez-Sabadell, B Morancho, IR Ruiz, MR Alonso, PO Romero, ... Cell Reports 41 (3), 2022 | 6 | 2022 |
| Human metastatic cholangiocarcinoma patient-derived xenografts and tumoroids for preclinical drug evaluation Q Serra-Camprubí, H Verdaguer, W Oliveros, N Lupión-Garcia, ... Clinical Cancer Research 29 (2), 432-445, 2023 | 3 | 2023 |
| Evaluation of triple negative breast cancer with heterogeneous immune infiltration Á Quintana, EJ Arenas, C Bernadó, JF Navarro, J González, ... Frontiers in Immunology 14, 1149747, 2023 | 2 | 2023 |
| Protocol to generate a patient derived xenograft model of acquired resistance to immunotherapy in humanized mice A Martínez-Sabadell, PO Romero, J Arribas, EJ Arenas STAR protocols 3 (4), 101712, 2022 | 2 | 2022 |
| AXL-a new player in resistance to HER2 blockade A Adam-Artigues, EJ Arenas, J Arribas, A Prat, JM Cejalvo Cancer Treatment Reviews, 102639, 2023 | 1 | 2023 |
| Mammary cancer stem cells reinitiation assessment at the metastatic niche: the lung and bone M Guiu, EJ Arenas, S Gawrzak, M Pavlovic, RR Gomis Mammary Stem Cells: Methods and Protocols, 221-229, 2015 | 1 | 2015 |
| Abstract C060: Characterization of a collection of patient-derived xenograft models for pancreatic ductal adenocarcinoma translational research M Yáñez, EJ Arenas, T Macarulla, T Tian, J Arribas, S Llorente, ... Cancer Research 84 (2_Supplement), C060-C060, 2024 | | 2024 |
